Neurobiology of Aging
Volume 30, Issue 5 , Pages 739-751 , May 2009

Prominent phenotypic variability associated with mutations in Progranulin

  • Brendan J. Kelley

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    • Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation, USA
    • ,
  • Wael Haidar

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    • Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation, USA
    • ,
  • Bradley F. Boeve

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    • Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation, USA
    • Corresponding Author InformationCorresponding author at: Mayo Clinic, Department of Neurology, 200 First Street SW, Rochester, MN 55905, USA. Tel.: +1 507 538 1038; fax: +1 507 538 6012.
    • ,
  • Matt Baker

      Affiliations

    • Neurogenetics Laboratory, Mayo Clinic, Jacksonville, FL 32224, USA
    • ,
  • Neill R. Graff-Radford

      Affiliations

    • Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
    • ,
  • Thomas Krefft

      Affiliations

    • Neurology Clinic, Slidell, LA 70458, USA
    • ,
  • Andrew R. Frank

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    • Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation, USA
    • ,
  • Clifford R. Jack Jr.

      Affiliations

    • Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
    • ,
  • Maria Shiung

      Affiliations

    • Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
    • ,
  • David S. Knopman

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    • Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation, USA
    • ,
  • Keith A. Josephs

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    • ,
  • Sotirios A. Parashos

      Affiliations

    • Struthers Parkinson's Center, Golden Valley, MN 55427, USA
    • ,
  • Rosa Rademakers

      Affiliations

    • Neurogenetics Laboratory, Mayo Clinic, Jacksonville, FL 32224, USA
    • ,
  • Mike Hutton

      Affiliations

    • Neurogenetics Laboratory, Mayo Clinic, Jacksonville, FL 32224, USA
    • ,
  • Stuart Pickering-Brown

      Affiliations

    • Centre for Clinical Neurosciences, University of Manchester, Salford M6 8HD, UK
    • ,
  • Jennifer Adamson

      Affiliations

    • Neurogenetics Laboratory, Mayo Clinic, Jacksonville, FL 32224, USA
    • ,
  • Karen M. Kuntz

      Affiliations

    • Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation, USA
    • ,
  • Dennis W. Dickson

      Affiliations

    • Neuropathology Laboratory, Mayo Clinic, Jacksonville, FL 32224, USA
    • ,
  • Joseph E. Parisi

      Affiliations

    • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
    • ,
  • Glenn E. Smith

      Affiliations

    • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA
    • Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation, USA
    • ,
  • Robert J. Ivnik

      Affiliations

    • Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA
    • Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation, USA
    • ,
  • Ronald C. Petersen

      Affiliations

    • Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
    • Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation, USA

Received 9 July 2007 ,Revised 27 July 2007 ,Accepted 26 August 2007.

References 

  1. Baba Y, Tsuboi Y, Baker MC, Uitti RJ, Hutton ML, Dickson DW, et al. The effect of tau genotype on clinical features in ftdp-17. Parkinsonism Relat. Disord. 2005;11(4):205–208
  2. Baba Y, Baker MC, Le Ber I, Brice A, Maeck L, Kohlhase J, et al. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a p301s tau mutation. J. Neural. Transm. 2007;(Epub ahead of print)
  3. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916–919
  4. Basun H, Almkvist O, Axelman K, Brun A, Campbell TA, Collinge J, et al. Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia. Arch. Neurol. 1997;54(5):539–544
  5. Benussi L, Binetti G, Sina E, Gigola L, Bettecken T, Meitinger T, et al. A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol. Aging. 2006;(Epub ahead of print)
  6. Bird TD, Nochlin D, Poorkaj P, Cherrier M, Kaye J, Payami H, et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301l). Brain. 1999;122(Pt 4):741–756
  7. Boeve BF, Maraganore DM, Parisi JE, Ivnik RJ, Westmoreland BF, Dickson DW, et al. Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology. Dement. Geriatr. Cogn. Disord. 2002;13(2):80–90
  8. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann. Neurol. 2003;54(Suppl. 5):S15–S19
  9. Boeve BF, Tremont-Lukats IW, Waclawik AJ, Murrell JR, Hermann B, Jack CR, et al. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the s305n tau mutation. Brain. 2005;128(Pt 4):752–772
  10. Boeve BF, Baker M, Dickson DW, Parisi JE, Giannini C, Josephs KA, et al. Frontotemporal dementia and parkinsonism associated with the IVS1+1G→A mutation in progranulin: a clinicopathologic study. Brain. 2006;129(Pt 11):3103–3114
  11. Brown J, Lantos PL, Rossor MN. Familial dementia lacking specific pathological features presenting with clinical features of corticobasal degeneration. J. Neurol. Neurosurg. Psychiatry. 1998;65(4):600–603
  12. Brown J, Gydesen S, Johannsen P, Gade A, Skibinski G, Chakrabarti L, et al. Frontotemporal dementia linked to chromosome 3. Dement. Geriatr. Cogn. Disord. 2004;17(4):274–276
  13. Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, Tabaton M, et al. Frontotemporal dementia and corticobasal degeneration in a family with a p301s mutation in tau. J. Neuropathol. Exp. Neurol. 1999;58(6):667–677
  14. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920–924
  15. Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, Drachman DA, et al. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J. Neuropathol. Exp. Neurol. 2006;65(6):571–581
  16. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D’Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference participants. Ann. Neurol. 1997;41(6):706–715
  17. Frank AR, Wszolek ZK, Jack CR, Boeve BF. Distinctive MRI findings in pallidopontonigral degeneration (PPND). Neurology. 2007;68(8):620–621
  18. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum. Mol. Genet. 2006;15(20):2988–3001
  19. Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, et al Fatal familial insomnia and familial Creutzfeldt–Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 1992;258(5083):806–808
  20. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov. Disord. 1999;14(4):674–680
  21. Huey ED, Grafman J, Wassermann EM, Pietrini P, Tierney MC, Ghetti B, et al. Characteristics of frontotemporal dementia patients with a progranulin mutation. Ann. Neurol. 2006;60(3):374–380
  22. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702–705
  23. Ingram EM, Spillantini MG. Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 2002;8(12):555–562
  24. Josephs KA, Holton JL, Rossor MN, Godbolt AK, Ozawa T, Strand K, et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol. Appl. Neurobiol. 2004;30(4):369–373
  25. Josephs KA, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Arch. Neurol. 2006;63(4):506–512
  26. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66(1):41–48
  27. Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J. Neuropathol. Exp. Neurol. 2007;66(2):142–151
  28. Kertesz A, Kawarai T, Rogaeva E, St George-Hyslop P, Poorkaj P, Bird TD, et al. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology. 2000;54(4):818–827
  29. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128(Pt 9):1996–2005
  30. Knopman DS, Mastri AR, Frey WH, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology. 1990;40(2):251–256
  31. Lipton AM, White CL, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol. (Berl.). 2004;108(5):379–385
  32. Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain. 2006;129(Pt 11):3081–3090
  33. Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain. 2006;129(Pt 4):853–867
  34. Mackenzie IR, Shi J, Shaw CL, Duplessis D, Neary D, Snowden JS, et al. Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol. (Berl.). 2006;112(5):551–559
  35. Masellis M, Momeni P, Meschino W, Heffner R, Elder J, Sato C, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain. 2006;129(Pt 11):3115–3123
  36. McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005;65(12):1863–1872
  37. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick's disease. Arch. Neurol. 2001;58(11):1803–1809
  38. Meiner Z, Newman JP, Rosenman H, Soffer D, Steiner I. Frontotemporal dementia with ubiquitinated neuronal inclusions and visuospatial impairment. Neurology. 2005;65(3):478–480
  39. Members of the Department of Neurology, M.C., 1998. Clinical examinations in neurology. Mosby, St. Louis.
  40. Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, Adamson JL, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch. Neurol. 2007;64(1):43–47
  41. Mukherjee O, Pastor P, Cairns NJ, Chakraverty S, Kauwe JS, Shears S, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann. Neurol. 2006;60(3):314–322
  42. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546–1554
  43. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–133
  44. Rademakers R, Cruts M, Dermaut B, Sleegers K, Rosso SM, Van den Broeck M, et al. Tau negative frontal lobe dementia at 17q21: Significant finemapping of the candidate region to a 4.8cm interval. Mol. Psychiatry. 2002;7(10):1064–1074
  45. Rosso SM, Kamphorst W, de Graaf B, Willemsen R, Ravid R, Niermeijer MF, et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain. 2001;124(Pt 10):1948–1957
  46. Savioz A, Riederer BM, Heutink P, Rizzu P, Tolnay M, Kovari E, et al. Tau and neurofilaments in a family with frontotemporal dementia unlinked to chromosome 17q21-22. Neurobiol. Dis. 2003;12(1):46–55
  47. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, et al. Mutations in the endosomal escrtii-complex subunit CHMP2b in frontotemporal dementia. Nat. Genet. 2005;37(8):806–808
  48. Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, Neary D, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129(Pt 11):3091–3102
  49. Spina S, Murrell JR, Huey ED, Wassermann EM, Pietrini P, Baraibar MA, et al. Clinicopathologic features of frontotemporal dementia with progranulin sequence variation. Neurology. 2007;68(11):820–827
  50. Suzuki M, Nishiahara M. Granulin precursor gene: a sex steroid-inducible gene involved in sexual differentiation of the rat brain. Mol. Genet. Metab. 2002;75(1):31–37
  51. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging. 1997;18(4 Suppl.):S1–S2
  52. van der Zee J, Rademakers R, Engelborghs S, Gijselinck I, Bogaerts V, Vandenberghe R, et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain. 2006;129(Pt 4):841–852
  53. Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, Sreedharan J, et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain. 2006;129(Pt 4):868–876
  54. Whitwell JL, Jack CR, Baker M, Rademakers R, Adamson J, Boeve BF, et al. Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch. Neurol. 2007;64(3):371–376

PII: S0197-4580(07)00352-1

doi: 10.1016/j.neurobiolaging.2007.08.022

Neurobiology of Aging
Volume 30, Issue 5 , Pages 739-751 , May 2009

Article Tools

* Image Usage & Resolution